ACMG the Latest to Come Out Against Genetic Testing for All Breast Cancer Patients

The debate over the need for genetic testing of all breast cancer patients for germline pathogenic or likely pathogenic variants in BRCA1, BRCA2 and other breast cancer-linked genes continues with the … [Read more...]

FDA WATCH

FDA Watch: Agency Resounds the Alarm on Biotin Test Interference

In early November 2019, the U.S. Food and Drug Administration (FDA) updated a previous safety communication about the potential of biotin to significantly interfere with diagnostic tests. The … [Read more...]

TESTING TRENDS

Testing Trends: The Debate Continues Over Regular Colorectal Screening for Average Risk Adults

Should adults age 50 to 75 who are at average risk and show no symptoms of colorectal cancer have regular colorectal screening exams? Last month, a major medical journal came out against regular … [Read more...]

GENETIC TESTING

Genetics Update: Internet Use Can Help Patients Self-Diagnose Rare Genetic Disorders

The notion of empowering patients to take control over their own health care is particularly powerful within the realm of genomic diagnostics to the extent that patients can theoretically seek their … [Read more...]

EMERGING TESTS

Nonculture Molecular Tests Speed Diagnosis of Bloodstream Infections

The T2Bacteria Panel (T2Biosystems; Lexington, Mass.) can rapidly and accurately diagnoses bloodstream infections (BSIs) caused by five common bacteria, according to a study published May 14 in the … [Read more...]

TESTING STRATEGY

Upfront Next-Generation Sequencing for Lung Cancer Patients Saves Time, Money

Use of upfront next-generation sequencing (NGS) testing at diagnosis of patients with metastatic non-small-cell lung cancer (mNSCLC) is associated with substantial cost savings, according to a study … [Read more...]

TESTING TRENDS

Genetic Testing Guidelines for Hereditary Cancer Miss Many At Risk

The National Comprehensive Cancer Network genetic testing criteria for hereditary cancer miss almost one in five at-risk for breast and ovarian cancer, and more than one in three at-risk for Lynch … [Read more...]

GENETIC TESTING

Expanded Access to Genetic Testing for Cardiomyopathy Is Cost Effective

Expansion of genetic testing in asymptomatic relatives of patients with dilated cardiomyopathy (DCM) to guide clinical surveillance is cost-effective, according to a study published in Genetics in … [Read more...]

TESTING STRATEGY

Routine Urine Test Can Screen for Medication Adherence at Primary Care Visit

A single urine spot sample can be used to objectively screen for nonadherence to diabetes medications in the primary care setting, according to a study published in the June issue of Diabetes Care. … [Read more...]

TESTING TRENDS

Search Intensifies for Markers for Prosthetic Joint Infection

Nearly one million total hip arthroplasties and total knee arthroplasties are performed in the United States each year, a number that is expected to continue to increase for decades given the aging of … [Read more...]


(-00000g2)